These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6681739)

  • 21. Plasma prednisolone levels from enteric and non-enteric coated tablets estimated by an original technique.
    Morrison PJ; Bradbrook ID; Rogers HJ
    Br J Clin Pharmacol; 1977 Oct; 4(5):597-603. PubMed ID: 911606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioavailability of prednisolone in patients with intestinal malabsorption: the importance of measuring serum protein-binding.
    Bergrem H; Opedal I
    Scand J Gastroenterol; 1983 May; 18(4):545-9. PubMed ID: 6669930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marked interspecies differences between humans and pigs in cyclosporine and prednisolone disposition.
    Frey BM; Sieber M; Mettler D; Gänger H; Frey FJ
    Drug Metab Dispos; 1988; 16(2):285-9. PubMed ID: 2898348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Removal of prednisone and prednisolone by plasma exchange.
    Stigelman WH; Henry DH; Talbert RL; Townsend RJ
    Clin Pharm; 1984; 3(4):402-7. PubMed ID: 6467876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The dose-dependent systemic availability of prednisone: one reason for the reduced biological effect of alternate-day prednisone.
    Frey FJ; Rüegsegger MK; Frey BM
    Br J Clin Pharmacol; 1986 Feb; 21(2):183-9. PubMed ID: 3954934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia.
    Petersen KB; Jusko WJ; Rasmussen M; Schmiegelow K
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):465-73. PubMed ID: 12698270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prednisolone pharmacokinetics compared between night and day in asthmatic and normal subjects.
    McAllister WA; Mitchell DM; Collins JV
    Br J Clin Pharmacol; 1981 Mar; 11(3):303-4. PubMed ID: 7194101
    [No Abstract]   [Full Text] [Related]  

  • 28. Diurnal variation in valproic acid clearance.
    Bauer LA; Davis R; Wilensky A; Raisys V; Levy RH
    Clin Pharmacol Ther; 1984 Apr; 35(4):505-9. PubMed ID: 6423338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect on nephrotic syndrome on absorption and disposition of prednisolone in children.
    Rocci ML; Assael BM; Appiani AC; Edefonti A; Jusko WJ
    Int J Pediatr Nephrol; 1982 Sep; 3(3):159-66. PubMed ID: 7141787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative bioavailability of prednisone and prednisolone in man.
    Tse FL; Welling PG
    J Pharm Pharmacol; 1979 Jul; 31(7):492-3. PubMed ID: 38330
    [No Abstract]   [Full Text] [Related]  

  • 31. Prednisolone disposition in obese men.
    Milsap RL; Plaisance KI; Jusko WJ
    Clin Pharmacol Ther; 1984 Dec; 36(6):824-31. PubMed ID: 6499362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of food and tablet formulation on plasma prednisolone levels following administration of enteric-coated tablets.
    Lee DA; Taylor GM; Walker JG; James VH
    Br J Clin Pharmacol; 1979 May; 7(5):523-8. PubMed ID: 475947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pharmacokinetics of fluocortolone and prednisolone after intravenous and oral administration.
    Täuber U; Haack D; Nieuweboer B; Kloss G; Vecsei P; Wendt H
    Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):48-55. PubMed ID: 6698661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prednisone for chronic active liver disease: pharmacokinetics, including conversion to prednisolone.
    Schalm SW; Summerskill WH; Go VL
    Gastroenterology; 1977 May; 72(5 Pt 1):910-3. PubMed ID: 849821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cortisol does not inhibit prednisolone clearance.
    Meffin PJ; Sallustio BC; Purdie YJ; Robson RA; Wing LM; Brooks PM
    Br J Clin Pharmacol; 1985 Oct; 20(4):414-6. PubMed ID: 4074609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of prednisolone injections in early postnatal ontogeny on the circadian rhythm of corticosteroid function in adult rats].
    Markel' AL; Kazin EM; Lur'e SB; Naumenko EV
    Ontogenez; 1978; 9(2):160-5. PubMed ID: 643245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of prednisolone after high doses of prednisolone hemisuccinate.
    Derendorf H; Rohdewald P; Möllmann H; Rehder J; Barth J; Neveling D
    Biopharm Drug Dispos; 1985; 6(4):423-32. PubMed ID: 4084667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prednisolone disposition and protein binding in oral contraceptive users.
    Boekenoogen SJ; Szefler SJ; Jusko WJ
    J Clin Endocrinol Metab; 1983 Apr; 56(4):702-9. PubMed ID: 6833459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prednisolone clearance at steady state in man.
    Legler UF; Frey FJ; Benet LZ
    J Clin Endocrinol Metab; 1982 Oct; 55(4):762-7. PubMed ID: 7107818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of pharmacokinetic diurnal variation on bioavailability estimates.
    Bauer LA; Gibaldi M; Vestal RE
    Clin Pharmacokinet; 1984; 9(2):184-7. PubMed ID: 6538824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.